Metastatic non small cell lung cancer (Phase I and expansion cohorts) research hub

An open-label, multicentric, phase I study with expansion cohorts, evaluating the safety and the efficacy of combination of atezolizumab, tiragolumab and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

This study is testing a new combination treatment for advanced cancers that have spread. It uses two immunotherapy drugs, atezolizumab and tiragolumab, along with focused radiation therapy. The main goal is to see if this treatment is safe and effective in fighting different types of cancer.